InSysBio, one of the world’s pioneers of Quantitative Systems Pharmacology (QSP) modeling, launches a new data annotation service designed to support researchers and analysts who require specific, literature-based biological data for use in QSP modeling, analysis, or decision-making.
The new service allows clients to submit targeted data requests related to diseases, tissues, cell types, and cytokines. InSysBio team will populate its CYTOCON or fIVE databases with newly curated data, ensuring availability in the most convenient and standardized format for subsequent analysis and integration.
Key features of the deliverables (all integrated into CYTOCON DB and fIVE DB):
1. Annotated Data Tables:
2. Summary Statistics Table
3. Visualizations
Each data request follows a one-month workflow. The first week is dedicated to a feasibility assessment, during which the team evaluates the availability and volume of the requested data in scientific literature. If the data cannot be identified, clients receive detailed feedback, and the query may be refined. Depending on the scope and complexity of the request, the team can process up to 20 scientific articles per month, resulting in approximately 800 annotated concentration values for CYTOCON DB and 130 annotated parameters for fIVE DB. All annotations are performed by a dedicated team consisting of one professional annotator and one reviewer, ensuring a high standard of quality and consistency throughout the process.
For further details or to data request, please feel free to contact us: support@insysbio.com
To learn more about CYTOCON DB, please visit https://cytocon.insysbio.com/Index.aspx
To learn more about fIVE DB, please visit https://5db.insysbio.com/Index.aspx
About InSysBio
InSysBio is a group of Quantitative Systems Pharmacology (QSP) companies located in Limassol, Cyprus (INSYSBIO CY Ltd) and Edinburgh, UK (INSYSBIO UK LIMITED). InSysBio was founded in 2004 and has an extensive track record of helping pharmaceutical companies to make right decisions on the critical stages of drug research and development by application of QSP modeling. InSysBio’s cutting-edge QSP approach has already become a part of the drug development process implemented by our strategic partners: there are more than 100 completed projects in collaboration with leaders of pharmaceutical industry and innovative biotech companies. For more information about InSysBio, its solutions and services, visit www.insysbio.com
| ← | August 2021 | → | ||||
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
|
1
| ||||||
|
2
1.
02 Aug 2021 16:17
InSysBio to take part in PharmSci360 2021
InSysBio announces its participation in AAPS 2021 PHARMSCI 360 which is to be held in Pennsylvania Convention Center, Philadelphia, PA, and Online 17-20 October, 2021. InSysBio team is going to present the update at the Virtual Booth (VB1) and 2 posters in frames of the Conference
|
3
|
4
|
5
|
6
1.
06 Aug 2021 15:38
InSysBio to participate in Biomarkers for Alzheimer’s Disease Summit
InSysBio will take part in Annual Biomarkers for Alzheimer’s Disease Summit, Digital Event which is going to be held August 24-26, 2021. InSysBio will present its Neurodegeneration modeling issues and Alzheimer’s Disease Platform update at its Virtual Booth! Moreover, Tatiana Karelina, Head of Neurodegenerative Diseases Modeling Team, will give a talk
|
7
|
8
|
|
9
|
10
|
11
1.
11 Aug 2021 15:50
InSysBio to launch its OpenSource HetaSimulator project
The new platform is a part of Heta-based QSP modeling infrastructure
[Moscow – 11.08.2021] InSysBio, one of the world’s pioneers of Quantitative Systems Pharmacology (QSP) modeling, now presents HetaSimulator. It is a part of Heta project that embraces three components. HetaSimulator is an OpenSource simulation and parameters estimation platform for the Heta modeling language.
|
12
|
13
|
14
|
15
|
|
16
|
17
|
18
1.
18 Aug 2021 10:49
InSysBio to take part in PAGE 2021
InSysBio announces its participation in PAGE 2021 Online meeting which is to be held on the 2nd, 3rd, 6th, and 7th of September 2021. InSysBio team is going to present its latest development at the Virtual Exhibition e-booth and six posters
|
19
|
20
|
21
|
22
|
|
23
|
24
|
25
|
26
|
27
|
28
|
29
|
|
30
|
31
| |||||